Publications

AuthorsTitlePublished DateJournalHTML Citation Link
Turner N, Strand A, Grewal D, Cox G, Arif S, Baker AW, Maziarz EK, Saullo JH, Wolfe CR.Use of Letermovir as Salvage Therapy for Drug-resistant CMV: A Case Series2019-03-01Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02337-18. doi: 10.1128/AAC.02337-18. Print 2019 Mar
Holland TL, Chambers HF, Boucher HW, Corey GR, Coleman R, Castaneda-Ruiz B, Fowler VG JrConsiderations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults2019-02-15Clin Infect DisClin Infect Dis. 2019 Feb 15;68(5):865-872. doi: 10.1093/cid/ciy774
Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheelter M, Tolomeo P, Han JHThe role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study2019-02-14BMC Infect DisBMC Infect Dis. 2019 Feb 14;19(1):163. doi: 10.1186/s12879-019-3804-y
Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman-Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Misch EA, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer MFecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience2019-02-01Am J TransplantAm J Transplant. 2018 Aug 7. doi: 10.1111/ajt.15058. [Epub ahead of print]
Jacobs MR, Abdelhamed AM, Good CE, Rhoads DD, Hujer KM, Hujer AM, Domitrovic TN, Rudin SD, Fouts DE, Richter SS, van Duin D, Kreiswirth BN, Bonomo RAARGONAUT-I: Activity of cefiderocol (S-649266), a siderophore cephalosporin, against Gram negative bacteria including carbapenem resistant nonfermenters and Enterobacteriaceae with defined extended-spectrum ?-lactamases and carbapenemases2018-12-21Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01801-18. doi: 10.1128/AAC.01801-18. Print 2019 Jan.
Luterbach CL, Boshe A, Henderson H, Cober E, Richter SS, Salata RA, Kalayjian RC, Watkins RR, Hujer AM, Hujer KM, Rudin SD, Domitrovic TN, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, van Duin DThe Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae2018-12-14Open Forum Infect DisOpen Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.
Anesi JA, Lautenbach E, Nachamkin I, Garrigan C, Bilker WB, Omorogbe J, Dankwa L, Wheeler MK, Tolomeo P, Han JH; CDC Prevention Epicenters Program.Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae2018-12-01Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2018 Dec;39(12):1431-1435. doi: 10.1017/ice.2018.254. Epub 2018 Oct 30.
Evans S, Rubin DB, Powers JH, Follmann.Analysis Populations in Anti-Infective Clinical Trials: Whom to Analyze?2018-12-01Stat Commun Infect DisStat Commun Infect Dis. 2018 Dec;10(1). pii: 20170002. doi: 10.1515/scid-2017-0002. Epub 2018 Aug 29
van Duin D, Gu P, Dong J, Pfaff M, Arias RM, Evans B, Yu Y, Li L, Zhang F, Liu Z, Cao B, Fowler VG, Wang MChina-United States Research Collaborations in Antimicrobial Resistance2018-11-14Clin Infect DisClin Infect Dis. 2018 Nov 13;67(suppl_2):S142-S145. doi: 10.1093/cid/ciy694.
Golpisamy SN, Woodworth MH,Wang T, Carpentieri C, Friedman-Moraco R, Mehta A, Larsen C, Kraft CThe use of microbiome restoration therapeutics to eliminate intestinal colonization with multi-drug resistant organisms2018-11-01Am J Med SciAm J Med Sci. 2018 Nov;356(5):433-440. doi: 10.1016/j.amjms.2018.08.015. Epub 2018 Aug 29.
Patel R, Fang FCDiagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership2018-08-16Clin Infect DisClin Infect Dis. 2018 Aug 16;67(5):799-801. doi: 10.1093/cid/ciy077.
Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA; Antibacterial Resistance Leadership Group.Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants (PROOF)2018-07-27Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00464-18. doi: 10.1128/AAC.00464-18. Print 2018 Aug.
Kebriaei R, Rice SA, Singh KV, Stamper KC, Dinh AQ, Rios R, Diaz L, Murray BE, Munita JM, Tran TT, Arias CA, Rybak MJInfluence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with ?-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions2018-07-27Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00315-18. doi: 10.1128/AAC.00315-18. Print 2018 Aug.
Tamma PD, Pierce VM, Cosgrove SE, Lautenbach E, Harris AD, Rayapati D, Han JHCan the Ceftriaxone Breakpoints be Increased without Compromising Patient Outcomes?2018-06-08Open Forum Infect DisOpen Forum Infect Dis. 2018 Jun 8;5(6):ofy139. doi: 10.1093/ofid/ofy139. eCollection 2018 Jun.
Miller WR, Seas C, Carvajal LP, Diaz L, Echeverri AM, Ferro C, Rios R, Porras P, Luna C, Gotuzzo E, Munita JM, Nannini E, Carcamo C, Reyes J, Arias CAThe Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia2018-05-23Open Forum Infect DisOpen Forum Infect Dis. 2018 May 23;5(6):ofy123. doi: 10.1093/ofid/ofy123. eCollection 2018 Jun 1.
Mamo Y, Woodworth MH, Wang T, Dhere T, Kraft CSDurability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection2018-05-17Clin Infect DisClin Infect Dis. 2018 May 17;66(11):1705-1711. doi: 10.1093/cid/cix1097.
Robinson ML, Kadam D, Kagal A, Khadse S, Kinikar A, Valvi C, Basavaraj A, Bharadwaj R, Marbaniang I, Kanade S, Raichur P, Sachs J, Klein E, Cosgrove S, Gupta A, Mave VAntibiotic Utilization and the Role of Suspected and Diagnosed Mosquito-borne Illness Among Adults and Children With Acute Febrile Illness in Pune, India2018-05-02Clin Infect DisClin Infect Dis. 2018 May 2;66(10):1602-1609. doi: 10.1093/cid/cix1059.
Richter SS, Karichu J, Otiso J, Van Heule H, Keller G, Cober E, Rojas LJ, Hujer AM, Hujer KM, Marshall S, Perez F, Rudin SD, Domitrovic TN, Kaye KS, Salata R, van Duin D, Bonomo RAEvaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins2018-05-01Diagn Microbiol Infect DisDiagn Microbiol Infect Dis. 2018 May;91(1):89-92.
Gopalsamy SN, Sherman A, Woodworth MH, Lutgring JD, Kraft CSFecal Microbiota Transplant for Multidrug-Resistant Organism Decolonization Administered During Septic Shock2018-04-01Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2018 Apr;39(4):490-492. doi: 10.1017/ice.2017.300. Epub 2018 Jan 18.
Kanwar A, Marshall SH, Perez F, Tomas M, Jacobs MR, Hujer AM, Domitrovic TN, Rudin SD, Rojas LJ, Kreiswirth BN, Chen L, Quinones-Mateu M, van Duin D, Bonomo RA; Antibacterial Resistance Leadership GroupEmergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae2018-04-01Open Forum Infect DisOpen Forum Infect Dis. 2018 Apr 23;5(4):ofy054. doi: 10.1093/ofid/ofy054. eCollection 2018 Apr.
Huskins WC, Fowler VG Jr, Evans SAdaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research2018-03-19Clin Infect DisClin Infect Dis. 2018 Mar 19;66(7):1140-1146. doi: 10.1093/cid/cix907.
Wang T, Kraft CS, Woodworth MH, Dhere T, Eaton MEFecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections2018-02-01Open Forum Infect DisOpen Forum Infect Dis. 2018 Jan 15;5(2):ofy016. doi: 10.1093/ofid/ofy016. eCollection 2018 Feb.
Open Forum Infect Dis. 2018 Jan 15;5(2):ofy016. doi: 10.1093/ofid/ofy016. eCollection 2018 Feb.
El Chakhtoura NG, Saade E, Iovleva A, Yasmin M, Wilson B, Perez F, Bonomo RATherapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy2018-02-01Expert Rev Anti Infect TherExpert Rev Anti Infect Ther. 2018 Feb;16(2):89-110. doi: 10.1080/14787210.2018.1425139. Epub 2018 Jan 16.
Hamasaki T, Evans SR, Asakura KDesign, data monitoring, and analysis of clinical trials with co-primary endpoints: A review2018-01-31J Biopharm StatJ Biopharm Stat. 2018;28(1):28-51. doi: 10.1080/10543406.2017.1378668. Epub 2017 Oct 30.
Tsalik EL, Bonomo RA, Fowler VGNew Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance2018-01-29Annu Rev MedAnnu Rev Med. 2018 Jan 29;69:379-394. doi: 10.1146/annurev-med-052716-030320.
Van Duin D, Lok J, Earley M, Cober E, Richter S, Perez F, Salata R, Kalayjian R, Watkins R, Doi Y, Kaye K, Fowler V Jr, Paterson D, Bonomo R, Evans SColistin Versus Ceftazidime-Avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae2018-01-06Clin Infect DisClin Infect Dis. 2018 Jan 6;66(2):163-171. doi: 10.1093/cid/cix783.
Chotiprasitsakul D, Han JH, Cosgrove SE, Harris AD, Lautenbach E, Conley AT, Tolomeo P, Wise J, & Tamma PD for the Antibacterial Resistance Leadership GroupComparing the Outcomes of Adults with Enterobacteriaceae Bacteremia Receiving Short-Course versus Prolonged-Course Antibiotic Therapy in a Propensity-Score Matched Multicenter Cohort2018-01-06Clin Infect DisClin Infect Dis. 2018 Jan 6;66(2):172-177. doi: 10.1093/cid/cix767.
Eilertson B, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Doi Y, Kaye KS, Evans S, Fowler VG, Bonomo RA, DeHovitz J, Kreiswirth B, van Duin D, for the ARLGCarbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy2017-10-06Open Forum Infect DisOpen Forum Infect Dis. 2017 Oct 6;4(4):ofx216. doi: 10.1093/ofid/ofx216. eCollection 2017 Fall.
Nielsen TB, Pantapalangkoor P, Yan J, Luna BM, Dekitani K, Bruhn K, Tan B, Junus J, Bonomo RA, Schmidt AM, Everson M, Duncanson F, Doherty TM, Lin L, Spellberg BDiabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE2017-08-22mBioMBio. 2017 Aug 22;8(4). pii: e00818-17.
Henig O, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Evans S, Fowler VG, Bonomo RA, van Duin D, Kaye KS, for the Antibacterial Resistance Leadership GroupA Prospective Observational Study of the Epidemiology, Management and Outcomes of Skin and Soft Tissue Infections due to Carbapenem-Resistant Enterobacteriaceae2017-07-27Open Forum Infect DisOpen Forum Infect Dis 2017;4(3):ofx157. https://doi.org/10.1093/ofid/ofx157
Thom KA, Rock C, Jackson SS, Johnson JK, Srinivasan A, Magder LS, Roghmann MC, Bonomo RA, Harris ADFactors Leading to Transmission Risk of Acinetobacter baumannii2017-07-01Crit Care MedCrit Care Med. 2017 Jul;45(7):e633-e639. doi: 10.1097/CCM.0000000000002318.
Asakura K, Hamasaki T, Evans SRInterim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints2017-07-01Biom JBiom J. 2017 Jul;59(4):703-731. doi: 10.1002/bimj.201600026. Epub 2016 Oct 19.
Rojas LJ, Hujer AM, Rudin SD, Wright MS, Domitrovic TN, Marshall SH, Hujer KM, Richter SS, Cober E, Perez F, Adams MD, van Duin D, Bonomo RANDM-5 and OXA-181 Beta-Lactamases, a Significant Threat Continues To Spread in the Americas.2017-06-27Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00454-17. doi: 10.1128/AAC.00454-17. Print 2017 Jul.
Shin WS, Bergstrom A, Bonomo RA, Crowder MW, Muthyala R, Sham YYDiscovery of 1-Hydroxypyridine-2(1H)-thione-6-carboxylic Acid as aFirst-in-Class Low-Cytotoxic Nanomolar Metallo beta-Lactamase Inhibitor2017-06-07ChemMedChemChemMedChem. 2017 Jun 7;12(11):845-849. doi: 10.1002/cmdc.201700182. Epub 2017 May 22.
Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TTT, Domitrovic TN, Higgins PG, Seifert H, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler VG Jr, Chambers HF, Bonomo RACorrection for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III"2017-06-01J Clin MicrobiolJ Clin Microbiol. 2017 Jun;55(6):1970. doi: 10.1128/JCM.00525-17.
Thaden JT, Park LP, Maskarinec SA, Ruffin F, Fowler VG, Van Duin DResults from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria2017-05-24Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 May 24;61(6). pii: e02671-16.
Evans SR, Harris ADMethods and Issues in Studies of CRE2017-05-19VirulenceVirulence. 2017 May 19;8(4):453-459. doi: 10.1080/21505594.2016.1213473. Epub 2016 Jul 28.
Sugimoto T, Hamasaki T, Evans SR, Sozu TSizing clinical trials when comparing bivariate time-to-event outcomes2017-04-30Stat MedStat Med. 2017 Apr 30;36(9):1363-1382.
Ochiai T, Hamasaki T, Evans SR, Asakura K, Ohno YGroup-Sequential Three-Armnoninferiority Clinical Trial Designs2017-04-17J Biopharm StatJ Biopharm Stat. 2016 Feb 18:1-25.
Marshall S, Hujer AM, Rojas LJ, Papp-Wallace KM, Humphries RM, Spellberg B, Hujer KM, Marshall EK, Rudin SD, Perez F, Wilson BM, Wasserman RB, Chikowski L, Paterson DL, Vila AJ, van Duin D, Kreiswirth BN, Chambers HF, Fowler VG Jr, Jacobs MR, Pulse ME, Weiss WJ, Bonomo RACan Ceftazidime-Avibactam and Aztreonam Overcome Beta-Lactam Resistance Conferred by Metallo-beta-Lactamases in Enterobacteriaceae?2017-03-24Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02243-16.
Rojas LJ, Salim M, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Marshall S, Rudin SD, Domitrovic TN, Hujer AM, Hujer KM, Doi Y, Kaye KS, Evans SE, Fowler VG, Bonomo RA, van Duin DColistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(6):711-718. doi: 10.1093/cid/ciw805.
Murray B, Jezek ACID Supplement: The Antibacterial Resistance Leadership Group: The First Steps2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S1-S2. doi: 10.1093/cid/ciw823.
Chambers HF, Cross HR, Evans SR, Kreiswirth BN, Fowler VG, and the ARLGCID Supplement: The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S3-S7. doi: 10.1093/cid/ciw824.
Cross HR, Harris A, Arias RK, Chambers HF, Fowler VG, and the LOC of the ARLGCID Supplement: Transforming Concepts into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S8-S12. doi: 10.1093/cid/ciw825.
Manca C, Hill C, Hujer AM, Patel R, Evans SR, Bonomo RA, Kreiswirth BN, and the LC of the ARLGCID Supplement: Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S13-S17. doi: 10.1093/cid/ciw826.
Huvane J, Komarow L, Hill C, Tran T, Pereira C, Rosenkranz SL, Finnemeyer M, Earley M, Jiang J, Wangt R, Lok J, Evans SR, and the SDMC of the ARLGCID Supplement: Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S18-S23. doi: 10.1093/cid/ciw827.
Doernberg SB, Lodise TP, Thaden JT, Munita J, Cosgrove S, Arias C, Boucher H, Corey GR, Lowy F, Murray B, Miller LG, Holland, and the Gram-Positive Committee of the ARLGCID Supplement: Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S24-S29. doi: 10.1093/cid/ciw828.
Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, Thaden JT, Stryjewski ME, van Duin D, and the Gram-Negative Committee of the ARLGCID Supplement: Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S30-S35. doi: 10.1093/cid/ciw829.
Anderson DJ, Jenkins T, Evans S, Harris A, Weinstein R, Tamma P, Han J, Banarjee R, Patel R, Zaoutis T, Lautenbach E, and the Stewardship and Infection Control Committee of the ARLGCID Supplement: The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S36-S40. doi: 10.1093/cid/ciw830.
Tsalik EL, Petzold E, Kreiswirth BN, Bonomo RA, Banerjee R, Lautenbach E, Evans SR, Hanson KE, Patel R, and the Diagnostics and Devices Committee of the ARLGCID Supplement: Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group2017-03-15Clin Infect DisClin Infect Dis. 2017 Mar 15;64(suppl_1):S41-S47. doi: 10.1093/cid/ciw831.
Evans SR, Powers JEvaluating Anti-Infective Drugs in the Resistant Pathogen Setting: Can we Use External Controls?2017-03-14Stat Commun Infect DisStat Commun Infect Dis. 2017;9(1). pii: 20160003.
Haidar G, Clancy CJ, Shields RK, Hao B, Cheng S, Nguyen MHMutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum ?-Lactamases2017-02-23Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02097-16.
Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJEmergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections2017-02-23Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02097-16.
Patel R, Tsalik EL, Petzold E, Fowler VG, Klausner JD, Evans S, and the Antibaceterial Resistance Leadership GroupMASTERMIND – Bringing Microbial Diagnostics to the Clinic2017-02-01Clin Infect DisClin Infect Dis. 2017 Feb 1;64(3):355-360. doi: 10.1093/cid/ciw788. Epub 2016 Dec 7.
Viau RA, Kiedrowski LM, Kreiswirth BN, Adams M, Perez F, Marchaim D, Guerrero DM, Kaye KS, Logan LK, Villegas MV, Bonomo RAA Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLST2017-02-01Pathog ImmunPathog Immun. 2017;2(1):23-33. doi: 10.20411/pai.v2i1.99. Epub 2017 Feb 1.
Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg BClinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges2017-01-01Clin Microbiol RevClin Microbiol Rev. 2017 Jan;30(1):409-447.
Evans SR, Hujer AM, Jiang H, Hill CB, Hujer KM, Mediavilla JR, Manca C, Tran TT, Domitrovic TN, Higgins PG, Kreiswirth BN, Patel R, Jacobs MR, Chen L, Sampath R, Hall T, Marzan C, Fowler V, Chambers H, Bonomo RA, and the Antibacterial Resistance Leadership GroupInforming Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics (RMDs) to Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. PRIMERS III2016-12-28J Clin MicrobiolJ Clin Microbiol. 2016 Dec 28;55(1):134-144. doi: 10.1128/JCM.01524-16. Print 2017 Jan.
Spellberg B, Bonomo RAEditorial Commentary: Ceftazidime-Avibactam and Carbapenem-Resistant Enterobacteriaceae: ''We're Gonna Need a Bigger Boat''2016-12-15Clin Infect DisClin Infect Dis. 2016 Dec 15;63(12):1619-1621. Epub 2016 Sep 13.
Evans, SR, FollmannUsing Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation2016-12-06Stat Biopharm ResStat Biopharm Res 2016;8(4):386-393.
Pennello G, Pantoja-Galicia N, Evans SComparing diagnostic tests on benefit-risk2016-12-01J Biopharm StatJ Biopharm Stat. 2016;26(6):1083-1097. Epub 2016 Aug 22.
Banerjee R, Ozenci V, Patel RIndividualized Approaches Are Needed for Optimized Blood Cultures2016-11-15Clin Infect DisClin Infect Dis. 2016 Nov 15;63(10):1332-1339. Epub 2016 Aug 23.
Spellberg B, Bartlett JG, Gilbert DNHow to Pitch an Antibiotic Stewardship Program to the Hospital C-Suite2016-10-15Open Forum Infect DisOpen Forum Infect Dis. 2016 Oct 15;3(4):ofw210. eCollection 2016 Oct.
Patel RNew Developments in Clinical Bacteriology Laboratories2016-10-01Mayo Clin ProcMayo Clin Proc. 2016 Oct;91(10):1448-1459. doi: 10.1016/j.mayocp.2016.06.020. Epub 2016 Aug 21.
Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Massey CJ, Tamma PD; Antibacterial Resistance Leadership Group.A Clinical Decision Tree to Predict Whether a Bacteremic Patient Is Infected With an Extended-Spectrum ?-Lactamase-Producing Organism2016-10-01Clin Infect DisClin Infect Dis. 2016 Oct 1;63(7):896-903.
Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, Bonomo RA, Blumberg EASuccessful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen2016-10-01Transpl Infect DisTranspl Infect Dis. 2016 Oct;18(5):777-781.
Evans S, Pennello G, Pantoja-Galicia N, Jiang H, Hujer AM, Hujer KM, Manca C, Hill C, Jacobs MR, Chen L, Patel R, Kreiswirth BN, Bonomo RA, and the Antibacterial Resistance Leadership Group (ARLG)Benefit-Risk Evaluation for Diagnostics: a Framework (BED-FRAME)2016-09-15Clin Infect DisClin Infect Dis. 2016 Sep 15;63(6):812-7.
Spellberg BThe New Antibiotic Mantra-''Shorter Is Better''2016-09-01JAMA Intern MedJAMA Intern Med. 2016 Sep 1; 176(9): 1254–1255.
van Duin D, Bonomo RACeftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation Beta-Lactam/Beta-Lactamase Inhibitor Combinations2016-07-15Clin Infect DisClin Infect Dis. 2016 Jul 15;63(2):234-41.
Hauck C, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Scalera NM, Doi Y, Kaye KS, Evans S, Fowler Jr VG, Bonomo RA, van Duin D, for the Antibacterial Resistance Leadership GroupSpectrum of Excess Mortality due to Carbapenem-Resistant Klebsiella pneumoniae Infections2016-06-30Clin Microbiol InfectClin Microbiol Infect. 2016 Jun;22(6):513-9.
Perez F, El Chakhtoura NG, Papp-Wallace KM, Wilson BM, Bonomo RATreatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?2016-04-01Expert Opin PharmacotherExpert Opin Pharmacother. 2016 Apr;17(6):761-81.
Messina JA, Cober E, Richter SS, Perez F, Salata RA, Kalayjian RC, Watkins RR, Kaye KS, Evans S, Bonomo RA, Fowler Jr VG, van Duin DHospital Readmissions in Patients with Carbapenem-Resistant Klebsiella 1 pneumoniae2016-03-31Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2015 Dec 21:1-8. [Epub ahead of print]
Evans S, Follmann D, Schoenfeld D, Fowler VG Jr, Chambers HFReply to Phillips, Morris, and Walker2016-03-15Clin Infect DisClin Infect Dis. 2016 Mar 15;62(6):815-6.
Wright MS, Iovleva A, Jacobs MR, Bonomo RA, Adams MDGenome Dynamics of Multidrug-resistant Acinetobacter baumannii during Infection and Treatment2016-03-03Genome MedGenome Med. 2016 Mar 3;8(1):26. doi: 10.1186/s13073-016-0279-y.
Thaden JT, Keller AE, Shire NJ, Camara MM, Otterson L, Huband M, Guenther CM, Zhao W, Warrener P, Stover KC, Foslwer VG, DiGiandomenico APseudomonas aeruginosa Bacteremic Patients Exhibit Non-Protective Antibody Titers against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide2016-02-15J Infect DisJ Infect Dis. 2016 Feb 15;213(4):640-8
Tsalik EL, Henao R, Nichols M, Burke T, Ko ER, McClain MT, Hudson LL, Mazur A, Freeman DH, Veldman T, Langley RJ, Quackenbush EB, Glickman SW, Cairns CB, Jaehne AK, Rivers EP, Otero RM, Zaas AK, Kingsmore SF, Lucas J, Fowler VG, Carin L, Ginsburg GS, Woods CWHost Gene Expression Classifiers Diagnose Acute Respiratory Illness Etiology2016-01-20Sci Transl MedSci Transl Med. 2016 Jan 20;8(322):322ra11.
Evans S, Hujer AM, Jiang H, Hujer KM, Hall T, Marzan C, Jacobs MR, Sampath R, Ecker DJ, Manca C, Chavda K, Zhang P, Fernandez H, Chen L, Mediavilla J, Hill C, Perez F, Caliendo A, Fowler V, Chambers H, Kreiswirth B, Bonomo RA, and the Antimicrobial Resistance Leadership GroupRapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II2016-01-15Clin Infect DisClin Infect Dis. 2016 Jan 15;62(2):181-9
Messina JA, Thaden JT, Sharma-Kuinkel BK, Fowler VGImpact of Bacterial and Human Genetic Variation on Staphylococcus aureus Infections2016-01-14PLoS PathogensPLoS Pathog. 2016 Jan 14;12(1):e1005330.
Evans SR, Follmann DFundamentals and Innovation in Antibiotic Trials2015-12-17Stat Biopharm ResStat Biopharm Res. 2015;7(4):331-336.
Spellberg B, Doi YThe Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought2015-12-15J Infect DisJ Infect Dis. 2015 Dec 15;212(12):1853-5.
Ericson JE, Popoola VO, Smith PB, Benjamin DK, Fowler VG, Benjamin DK Jr, Clark RH, Milstone AMBurden of Invasive Staphylococcus aureus Infections in Hospitalized Infants2015-12-01JAMA PediatrJAMA Pediatr. 2015;169(12):1105-1111
Thaden JT, Ericson JE, Cross H, Bergin S, Messina JA, Fowler VG Jr, Benjamin DK Jr, Clark RH, Hornik CP, Smith PBSurvival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants2015-10-30Pediatr Infect Dis JPediatr Infect Dis J. 2015 Nov;34(11):1175-9.
Banerjee R,Teng C, Cunningham S, Ihde S, Steckelberg J, Moriarty JP, Shah ND, Mandrekar J, Patel RRandomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing2015-10-01Clin Infect DisClin Infect Dis. 2015 Oct 1;61(7):1071-80. doi: 10.1093/cid/civ447. Epub 2015 Jul 20.
Choe H, Narayanan AS, Gandhi DA, Weinberg A, Marcus RE, Lee Z, Bonomo RA, Greenfield EMImmunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration2015-09-30Clin Orthop Relat ResClin Orthop Relat Res. 2015 Sep;473(9):2898-907.
Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, Salata RA, van Duin D, Perez F, Bonomo RA, Paterson DL, Harris PNCommunity-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae2015-08-31Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2015 Aug;59(8):4375-8. doi: 10.1128/AAC.00553-15.
Bergin SP, Thaden J, Ericson JE, Cross H, Messina J, Clark RH, Fowler V, Benjamin DK, Hornik CP, Smith PBNeonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy2015-08-31Pediatr Infect Dis JPediatr Infect Dis J. 2015;34(9):933-936.
Evans SR, Rubin D, Follman D, Penello G, Huskins WC, Powers J, Schoenfeld D, Chuang-Stein C, Fowler V, Lautenbach E, Chambers HFDesirability of Outcome Ranking (DOOR) and Response Adjusted for Days of Antibiotic Risk (RADAR)2015-08-26Clin Infect DisClin Infect Dis. 2015 Sep 1;61(5):800-6.
van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RA, Kaye KSResidence in Skilled Nursing Facilities is associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae2015-08-26Infect Control Hosp EpidemiolInfect Control Hosp Epidemiol. 2015 Aug;36(8):942-8
Uno H, Wittes J, Fu H, Solomon SD, Claggett B, Tian L, Cai T, Pfeffer MA, Evans SR, Wei LJAlternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies2015-07-21Ann Intern MedAnn Intern Med. 2015 Jul 21;163(2):127-34.
Ando Y, Hamasaki T, Evans SR, Asakura K, Sugimoto T, Sozu T, Ohno YSample size considerations in clinical trials when comparing two interventions using multiple co-primary binary relative risk contrasts2015-06-24Stat Biopharm ResStat Biopharm Res. 2015 Jun 24;7(2):81-94.
Messina JA, Fowler VG Jr, Corey GROritavancin for Acute Bacterial Skin and Skin Structure Infections2015-05-17Expert Opin PharmacotherExpert Opin Pharmacother. 2015 May;16(7):1091-8.
Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE; for the Antibacterial Resistance Leadership GroupCarbapenem Therapy is Associated with Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum ?-Lactamase Bacteremia2015-05-01Clin Infect DisClin Infect Dis. 2015 May 1;60(9):1319-25. doi: 10.1093/cid/civ003. Epub 2015 Jan 13.
Hamasaki T, Asakura K, Evans SR, Sugimoto T, Suzo TGroup-sequential Strategies in Clinical Trials with Multiple Co-primary Outcomes2015-04-14Stat Biopharm ResStat Biopharm Res. 2015;7(1):36-54.
van Duin D, Cober E, Richter SS, Perez F, Kalayjian RC, Salata RA, Evans S, Fowler VG, Kaye KS, Bonomo RAImpact of Therapy and Strain Type on Outcomes in Urinary Tract Infections Caused by Carbapenem-Resistant Klebsiella Pneumoniae2015-04-01J Antimicrob ChemotherJ Antimicrob Chemother. 2015 Apr;70(4):1203-11
Tugal D, Lynch M, Hujer AM, Rudin S, Perez F, Bonomo RAMulti-Drug-Resistant Klebsiella pneumoniae Pancreatitis: A New Challenge in a Serious Surgical Infection2015-04-01Surg Infect (Larchmt)Surg Infect (Larchmt). 2015 Apr;16(2):188-93.
Ericson JE, Thaden J, Cross H, Clark RH, Fowler V, Benjamin DK Jr, Cohen-Wolkowiez M, Hornik CP, Smith PBNo Survival Benefit with Empirical Vancomycin Therapy for Coagulase-negative Staphylococcal Bloodstream Infections in Infants2015-03-17Pediatr Infect Dis JPediatr Infect Dis J. 2015 Apr;34(4):371-5.
Spellberg B, Barlett J, Wunderink R, Gilbert DNNovel Approaches Are Needed to Develop Tomorrow’s Antibacterial Therapies2015-01-15Am J Respir Crit Care MedAm J Respir Crit Care Med. 2015 Jan 15;191(2):135-40.
Wright MS, Suzuki Y, Jones MB, Marshall SH, Rudin SD, van Duin D, Kaye K, Jacobs M, Bonomo RA, Adams MDGenomic and Transcriptomic Analyses of Colistin-Resistant Clinical Isolates of Klebsiella pneumoniae Reveal Independent Pathways of Resistance2015-01-01Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2015 Jan;59(1):536-43. doi: 10.1128/AAC.04037-14. Epub 2014 Nov 10.
van Duin D, Cober E, Richter SS, Perez F, Cline M, Kaye KS, Kalayjian RC, Salata RA, Evans S, Fowler VG, Bonomo RATigecycline Therapy for Carbapenem-Resistant Klebsiella pneumoniae (CRKP) Bacteriuria Leads to Tigecycline Resistance2014-12-01Clin Microbiol InfectClin Microbiol Infect. 2014 Dec;20(12):O1117-20. doi: 10.1111/1469-0691.12714. Epub 2014 Dec 12.
Vazquez Melendez EL, Farrell JJ, Hujer AM, Lowery KS, Sampath R, Bonomo RACulture Negative Empyema in A Critically Ill Child: An Opportunity for Rapid Molecular Diagnostics2014-11-22BMC AnesthesiolBMC Anesthesiol. 2014 Nov 22;14:107. doi: 10.1186/1471-2253-14-107. eCollection 2014.
Perez F, Adachi J, Bonomo RAAntibiotic-Resistant Gram-Negative Bacterial Infections in Patients with Cancer2014-11-15Clin Infect DisClin Infect Dis. 2014 Nov 15;59 Suppl
5:S335-9. doi: 10.1093/cid/ciu612
Stafford KA, Boutin M, Evans SR, Harris ADDifficulties in Demonstrating Superiority of an Antibiotic for Multi-drug Resistant Bacteria in Non-Randomized Studies2014-10-15Clin Infect DisClin Infect Dis. 2014 Oct 15;59(8):1142-7. doi: 10.1093/cid/ciu486. Epub 2014 Jun 30.
Perez F, Hujer AM, Marshall SH, Ray AJ, Rather PN, Suwantarant N, Dumford D III, O’Shea P, Domitrovic TNJ, Salata RA, Chavda KD, Chen L, Kreiswirth BN, Vila AJ, Haussler SH, Jacobs MR, Bonomo RAExtensively Drug-Resistant Pseudomonas Aeruginosa Isolates Containing blaVIM-2 and Elements of Salmonella Genomic Island 2: A New Genetic Resistance Determinant in Northeast Ohio2014-10-01Antimicrob Agents ChemotherAntimicrob Agents
Chemother. 2014 Oct;58(10):5929-35. doi: 10.1128/AAC.02372-14. Epub 2014 Jul 28
Spellberg B, Gibert DNThe Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett2014-09-15Clin Infect DisClin Infect Dis. 2014 Sep 15;59 Suppl 2:S71-5. doi: 10.1093/cid/ciu392.
David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ, Garcia-Houchins S, Gialanella P, Macias-Gil R, Rude TH, Ruffin F, Sieth J, Volinski J, Spellberg BStaphylococcus aureus Bacteremia at Five U.S. Academic Medical Centers, 2008-2011: Significant Geographic Variation in Community-Onset Infections2014-09-15Clin Infect DisClin Infect Dis. 2014 Sep 15;59(6):798-807. doi: 10.1093/cid/ciu410. Epub 2014 May 30.
Holland TL, Arnold C, Fowler VG JrClinical Management of Staphylococcus aureus Bacteremia: A Review2014-09-01JAMAJAMA. 2014 Oct 1;312(13):1330-41. doi: 10.1001/jama.2014.9743.
Nagalingam S, Lisgaris M, Rodriguez B, Jacobs MR, Lederman M, Salata RA, Hujer AM, Muehlenbachs A, DeLeon-Carnes M, Farrell JJ, Sampath R, Bonomo RAIdentification of Occult Fusobacterium Nucleatum Central Nervous System Infection By Use of PCR-Electrospray Ionization Mass Spectrometry2014-09-01J Clin MicrobiolJ Clin Microbiol. 2014
Sep;52(9):3462-4. doi: 10.1128/JCM.01082-14. Epub 2014 Jun 25.
Wright MS, Perez F, Brinkac L, Jacobs MR, Kaye K, Cober E, van Duin D, Marshall SH, Hujer AM, Rudin SD, Hujer KM, Bonomo RA, Adams MDPopulation Structure of KPC-producing Klebsiella pneumoniae from Midwestern US hospitals2014-08-01Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2014 Aug;58(8):4961-5. doi: 10.1128/AAC.00125-14. Epub 2014 Jun 9.
Asakura K, Hamasaki T, Sugimoto T, Hayashi K, Evans SR, Sozu TSample Size Determination in Group-Sequential Clinical Trials with Two Co-Primary Endpoints2014-07-01Stat MedStat Med. 2014 Jul 30;33(17):2897-913. doi: 10.1002/sim.6154. Epub 2014 Mar 27.
van Duin D, Perez F, Rudin SD, Cober E, Hanrahan J, Ziegler J, Webber R, Fox J, Mason P, Cline M, Hall G, Kaye K, Jacobs J, Kalayjian RC, Salata RA, Ramirez MS, Tolmalsky M, Evans S, Fowler VG Jr, Bonomo RASurveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network2014-07-01Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2014 Jul;58(7):4035-41. doi: 10.1128/AAC.02636-14. Epub 2014 May 5.
Spellberg BThe Future of Antibiotics2014-06-27Crit CareCrit Care. 2014 Jun 27;18(3):228. doi: 10.1186/cc13948.
Ramirez MS, Xie G, Johnson S, Davenport K, van Duin D, Perez F, Bonomo RA, Chain P, Tolmasky MEGenome Sequences of Two Carbapenemase-Resistant Klebsiella pneumoniae ST258 Isolates2014-06-19Genome AnnouncGenome Announc. 2014 Jun 19;2(3). pii: e00558-14. doi: 10.1128/genomeA.00558-14.
Chambers HF, Bartlett JG, Bonomo RA, Chiou C, Cosgrove SE, Cross HR, Daum RS, Downing M, Evans SR, Knisely J, Kreiswirth BN, Lautenbach E, Mickley BS, Patel R, Pettigrew MM, Rodvold KA, Spellberg B, Fowler VG Jr.Antibacterial Resistance Leadership Group: Open for Business2014-06-01Clin Infect DisClin Infect Dis. 2014 Jun;58(11):1571-6. doi: 10.1093/cid/ciu132. Epub 2014 Mar 6.
Perez F, Bonomo RAVaccines for Acinetobacter baumannii: Thinking "Out of the Box"2014-05-07VaccineVaccine. 2014 May 7;32(22):2537-9.
Fowler VG Jr, Proctor RAWhere Does a Staphylococcus Aureus Vaccine Stand2014-05-01Clin Microbiol InfectClin Microbiol Infect. 2014 May;20 Suppl 5:66-75.
Spellberg BAntibiotic Judo: Working Gently with Prescriber Psychology to Overcome Inappropriate Use2014-03-31JAMA Intern MedJAMA Intern Med. 2014 Mar;174(3):432-3. doi: 10.1001/jamainternmed.2013.14019.
Perez F, Rudin SD, Marshall SH, Coakley P, Chen L, Kreiswirth BN, Rather PN, Hujer AM, Toltzis P, van Duin D, Paterson DL, Bonomo RAOqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin2013-09-01Antimicrob Agents ChemotherAntimicrob Agents Chemother. 2013 Sep;57(9):4602-3.